Skip to the page

Data / Drug companies / Radha Pharmaceuticals, Inc.

Radha Pharmaceuticals, Inc.: 45 products in the FDA NDC directory, labeler code 77771

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Radha Pharmaceuticals, Inc. (labeler code 77771) lists 45 products in the FDA National Drug Code Directory, covering 15 finished drugs by generic name. By type: 43 prescription drugs, 2 over the counter drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on July 14, 2026.

The request: Watch Radha Pharmaceuticals, Inc. (FDA labeler code 77771): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
77771
Products in commercial distribution
45
Packages
81
Finished drugs by generic name
15
Prescription products
43
Over the counter products
2
Flagged as original packager
41 of 41 products that carry the flag
Started marketing in the last 12 months
5
Earliest marketing start
March 4, 2021
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Generic drugs (ANDA)45100%

Products by type

TypeProductsShare
Prescription drugs4395.6%
Over the counter drugs24.4%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

Dosage forms

Dosage formProductsShare
Tablet2044.4%
Tablet, film coated817.8%
Tablet, film coated, extended release817.8%
Capsule715.6%
Tablet, extended release24.4%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Tofacitinib citrate77771-567Tablet, film coated, extended releaseGeneric drugs (ANDA)July 14, 2026
Fluconazole77771-399TabletGeneric drugs (ANDA)December 10, 2025
Fluconazole77771-398TabletGeneric drugs (ANDA)December 10, 2025
Fluconazole77771-397TabletGeneric drugs (ANDA)December 10, 2025
Fluconazole77771-396TabletGeneric drugs (ANDA)December 10, 2025
Ticagrelor77771-522TabletGeneric drugs (ANDA)October 9, 2025
Ticagrelor77771-521TabletGeneric drugs (ANDA)October 9, 2025
Buspirone hydrochloride77771-238TabletGeneric drugs (ANDA)September 18, 2025
Buspirone hydrochloride77771-237TabletGeneric drugs (ANDA)September 18, 2025
Buspirone hydrochloride77771-236TabletGeneric drugs (ANDA)September 18, 2025
Buspirone hydrochloride77771-235TabletGeneric drugs (ANDA)September 18, 2025
Buspirone hydrochloride77771-234TabletGeneric drugs (ANDA)September 18, 2025
Ranolazine77771-424Tablet, film coated, extended releaseGeneric drugs (ANDA)June 30, 2025
Ranolazine77771-423Tablet, film coated, extended releaseGeneric drugs (ANDA)June 30, 2025
Carbidopa and Levodopa77771-461Tablet, extended releaseGeneric drugs (ANDA)April 25, 2025
Carbidopa and Levodopa77771-460Tablet, extended releaseGeneric drugs (ANDA)April 25, 2025
Fexofenadine hcl77771-202Tablet, film coatedGeneric drugs (ANDA)March 10, 2025
Fexofenadine hcl77771-201Tablet, film coatedGeneric drugs (ANDA)March 10, 2025
Gabapentin77771-178TabletGeneric drugs (ANDA)November 3, 2023
Gabapentin77771-177TabletGeneric drugs (ANDA)November 3, 2023
Atorvastatin calcium77771-454Tablet, film coatedGeneric drugs (ANDA)August 10, 2023
Atorvastatin calcium77771-453Tablet, film coatedGeneric drugs (ANDA)August 10, 2023
Atorvastatin calcium77771-452Tablet, film coatedGeneric drugs (ANDA)August 10, 2023
Atorvastatin calcium77771-451Tablet, film coatedGeneric drugs (ANDA)August 10, 2023
Clopidogrel bisulfate77771-124Tablet, film coatedGeneric drugs (ANDA)February 20, 2023

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.